{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T01:56:07Z","timestamp":1785376567477,"version":"3.55.0"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"National Major New Drug Creation Program","award":["2009ZX09103-094"],"award-info":[{"award-number":["2009ZX09103-094"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation","doi-asserted-by":"publisher","award":["30973638"],"award-info":[{"award-number":["30973638"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vascular Pharmacology"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.vph.2016.12.003","type":"journal-article","created":{"date-parts":[[2017,1,7]],"date-time":"2017-01-07T07:31:40Z","timestamp":1483774300000},"page":"49-57","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["G004, a synthetic sulfonylurea compound, exerts anti-atherosclerosis effects by targeting SIRT1 in ApoE \u2212\/\u2212 mice"],"prefix":"10.1016","volume":"89","author":[{"given":"Lifen","family":"Qian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingman","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanzhong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6885-9901","authenticated-orcid":false,"given":"Qian","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huisheng","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qidi","family":"Ying","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7347","key":"10.1016\/j.vph.2016.12.003_bb0005","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nature10146","article-title":"Progress and challenges in translating the biology of atherosclerosis","volume":"473","author":"Libby","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.vph.2016.12.003_bb0010","series-title":"Molecular Biology of Atherosclerosis","author":"Hopkins","year":"2013"},{"issue":"1","key":"10.1016\/j.vph.2016.12.003_bb0015","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s11239-013-1026-5","article-title":"Thrombin generation and atherosclerosis","volume":"37","author":"Kalz","year":"2014","journal-title":"J. Thromb. Thrombolysis"},{"issue":"27","key":"10.1016\/j.vph.2016.12.003_bb0020","doi-asserted-by":"crossref","first-page":"3133","DOI":"10.2174\/138161209789058002","article-title":"Prevention of atherosclerosis by interference with the vascular nitric oxide system","volume":"15","author":"Li","year":"2009","journal-title":"Curr. Pharm. Des."},{"issue":"7","key":"10.1016\/j.vph.2016.12.003_bb0025","first-page":"264","article-title":"Nitric oxide synthases: regulation and function","volume":"33","author":"F\u00f6rstermann","year":"2011","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.vph.2016.12.003_bb0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2015\/924860","article-title":"Arginase as a critical prooxidant mediator in the binomial endothelial dysfunction-atherosclerosis","volume":"2015","author":"Rabelo","year":"2015","journal-title":"Oxidative Med. Cell. Longev."},{"issue":"2","key":"10.1016\/j.vph.2016.12.003_bb0035","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.jvs.2012.10.123","article-title":"Techniques to harvest diseased human peripheral arteries and measure endothelial function in an exvivo model","volume":"58","author":"Lakin","year":"2013","journal-title":"J. Vasc. Surg."},{"issue":"23","key":"10.1016\/j.vph.2016.12.003_bb0040","doi-asserted-by":"crossref","first-page":"5588","DOI":"10.1016\/j.febslet.2006.08.022","article-title":"Regulation of cholesterol homeostasis in macrophages and consequences for atherosclerotic lesion development","volume":"580","author":"Pennings","year":"2006","journal-title":"FEBS Lett."},{"issue":"2","key":"10.1016\/j.vph.2016.12.003_bb0045","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/MOL.0b013e3283508c21","article-title":"Biliary and nonbiliary contributions to reverse cholesterol transport","volume":"23","author":"Temel","year":"2012","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.vph.2016.12.003_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.nutres.2016.06.004","article-title":"Medium-chain triglycerides promote macrophage reverse cholesterol transport and improve atherosclerosis in ApoE-deficient mice fed a high-fat diet","author":"Zhang","year":"2016","journal-title":"Nutr. Res."},{"issue":"1","key":"10.1016\/j.vph.2016.12.003_bb0055","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.diabres.2010.12.023","article-title":"Effects of glimepiride and glibenclamide on carotid atherosclerosis in type 2 diabetic patients","volume":"92","author":"Katakami","year":"2011","journal-title":"Diabetes Res. Clin. Pract."},{"issue":"1","key":"10.1016\/j.vph.2016.12.003_bb0060","doi-asserted-by":"crossref","first-page":"5","DOI":"10.4103\/0975-3583.91592","article-title":"Evaluation of the effects of glimepiride (Amaryl) and repaglinide (novoNorm) on atherosclerosis progression in high cholesterol-fed male rabbits","volume":"3","author":"Hadi","year":"2012","journal-title":"J. Cardiovasc. Dis. Res."},{"issue":"6","key":"10.1016\/j.vph.2016.12.003_bb0065","first-page":"963","article-title":"Effects of pioglitazone and glipizide on platelet function in patients with type 2 diabetes","volume":"19","author":"Xiao","year":"2015","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"1","key":"10.1016\/j.vph.2016.12.003_bb0070","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S0026-0495(97)90312-7","article-title":"The effects of gliclazide and other sulfonylureas on low-density lipoprotein oxidation in vitro","volume":"46","author":"O'Brien","year":"1997","journal-title":"Metab. Clin. Exp."},{"issue":"6","key":"10.1016\/j.vph.2016.12.003_bb0075","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1016\/j.bmcl.2009.01.082","article-title":"Synthesis and biological evaluation of sulfonylurea and thiourea derivatives substituted with benzenesulfonamide groups as potential hypoglycemic agents","volume":"19","author":"Zhang","year":"2009","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"11","key":"10.1016\/j.vph.2016.12.003_bb0080","first-page":"550","article-title":"Effect of 1-[4-[2-(4-bromobenzenesulfonamino) ethyl] phenylsulfonyl]-3-(trans-4-methylcyclohexyl)urea (I4), a new synthetic sulfonylurea compound, on glucose metabolism in vivo and in vitro","volume":"59","author":"Wu","year":"2009","journal-title":"Arzneimittelforschung"},{"issue":"8","key":"10.1016\/j.vph.2016.12.003_bb0085","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1007\/s00210-015-1112-7","article-title":"Reno-protection of G004, a novel anti-diabetic sulfonylurea in db\/db mice","volume":"388","author":"Tong","year":"2015","journal-title":"Archiv F\u00fcr Experimentelle Pathologie Und Pharmakologie"},{"issue":"4","key":"10.1016\/j.vph.2016.12.003_bb0090","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.thromres.2012.07.022","article-title":"I 4 , a new synthetic sulfonylurea compound, inhibits the action of TXA 2 in vivo and in vitro on platelets and aorta vascular smooth muscle","volume":"130","author":"Lu","year":"2012","journal-title":"Thromb. Res."},{"key":"10.1016\/j.vph.2016.12.003_bb0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/09537104.2014.912749","article-title":"Antiplatelet aggregation and endothelial protection of I4, a new synthetic anti-diabetes sulfonylurea compound","volume":"26","author":"Ma","year":"2015","journal-title":"Platelets"},{"issue":"8","key":"10.1016\/j.vph.2016.12.003_bb0100","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1172\/JCI32057","article-title":"Macrophage ABCA1 and ABCG1, but not SR-BI, promote macrophage reverse cholesterol transport in vivo","volume":"117","author":"Wang","year":"2007","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.vph.2016.12.003_bb0105","article-title":"NAMPT knockdown attenuates atherosclerosis and promotes reverse cholesterol transport in ApoE KO mice with high-fat-induced insulin resistance","volume":"6","author":"Li","year":"2016","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.vph.2016.12.003_bb0110","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1161\/CIR.0b013e3182009701","article-title":"Executive summary: heart disease and stroke statistics\u20142011 update a report from the American Heart Association","volume":"123","author":"Roger","year":"2011","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.vph.2016.12.003_bb0115","first-page":"29","article-title":"Heart disease and stroke statistics\u20142011 update: a report from the American Heart Association","volume":"131","author":"Roger","year":"2014","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.vph.2016.12.003_bb0120","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1161\/01.cir.0000442015.53336.12","article-title":"Executive summary: heart disease and stroke statistics\u20142014 update: a report from the American Heart Association","volume":"129","author":"G.","year":"2014","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.vph.2016.12.003_bb0125","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1161\/ATVBAHA.110.221127","article-title":"Monocyte and macrophage dynamics during atherogenesis","volume":"31","author":"Ley","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"1","key":"10.1016\/j.vph.2016.12.003_bb0130","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jacc.2013.03.058","article-title":"Changes in plaque lipid content after short-term intensive versus standard StatinTherapy: the YELLOW trial (reduction in yellow plaque by aggressive lipid-lowering therapy)","volume":"62","author":"Kini","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"issue":"12","key":"10.1016\/j.vph.2016.12.003_bb0135","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.2165\/00003495-200161120-00012","article-title":"Atorvastatin: an updated review of its pharmacological properties and use in dyslipidaemia","volume":"61","author":"Malhotra","year":"2001","journal-title":"Drugs"},{"issue":"1","key":"10.1016\/j.vph.2016.12.003_bb0140","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.phrs.2011.02.008","article-title":"Simultaneous intake of oat bran and atorvastatin reduces their efficacy to lower lipid levels and atherosclerosis in LDLr\u2212\/\u2212 mice","volume":"64","author":"Eussen","year":"2011","journal-title":"Pharmacol. Res."},{"issue":"1","key":"10.1016\/j.vph.2016.12.003_bb0145","doi-asserted-by":"crossref","first-page":"950","DOI":"10.3390\/ijms16010950","article-title":"Diverse roles of SIRT1 in cancer biology and lipid metabolism","volume":"16","author":"Jr","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.vph.2016.12.003_bb0150","doi-asserted-by":"crossref","first-page":"469059","DOI":"10.1155\/2014\/469059","article-title":"Dietary blueberry and bifidobacteria attenuate nonalcoholic fatty liver disease in rats by affecting SIRT1-mediated signaling pathway","volume":"2014","author":"Ren","year":"2014","journal-title":"Oxidative Med. Cell. Longev."},{"issue":"1","key":"10.1016\/j.vph.2016.12.003_bb0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1464-5491.2007.02025.x","article-title":"Non-alcoholic fatty liver disease, the metabolic syndrome and the risk of cardiovascular disease: the plot thickens","volume":"24","author":"Targher","year":"2007","journal-title":"Diabet. Med."},{"issue":"2","key":"10.1016\/j.vph.2016.12.003_bb0160","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1053\/j.gastro.2013.10.059","article-title":"Hepatic SIRT1 attenuates hepatic steatosis and controls energy balance in mice by inducing fibroblast growth factor 21","volume":"146","author":"Li","year":"2014","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.vph.2016.12.003_bb0165","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.jhep.2012.11.042","article-title":"Inhibition of p53 attenuates steatosis and liver injury in a mouse model of non-alcoholic fatty liver disease","volume":"58","author":"Zoltan Derdak","year":"2013","journal-title":"J. Hepatol."},{"issue":"7","key":"10.1016\/j.vph.2016.12.003_bb0170","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.jnutbio.2014.02.010","article-title":"Extract of okra lowers blood glucose and serum lipids in high-fat diet-induced obese C57BL\/6 mice","volume":"25","author":"Fan","year":"2014","journal-title":"J. Nutr. Biochem."},{"issue":"5","key":"10.1016\/j.vph.2016.12.003_bb0175","first-page":"37","article-title":"Endothelial nitric oxide synthase in the vascular wall: mechanisms regulating its expression and enzymatic function","volume":"5","author":"Demosthenous","year":"2011","journal-title":"Arthritis Res."},{"issue":"37","key":"10.1016\/j.vph.2016.12.003_bb0180","doi-asserted-by":"crossref","first-page":"14855","DOI":"10.1073\/pnas.0704329104","article-title":"SIRT1 promotes endothelium-dependent vascular relaxation by activating endothelial nitric oxide synthase","volume":"104","author":"Mattagajasingh","year":"2007","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"3","key":"10.1016\/j.vph.2016.12.003_bb0185","first-page":"271","article-title":"Role of SIRT1 and FOXO factors in eNOS transcriptional activation by resveratrol","volume":"32","author":"Xia","year":"2013","journal-title":"Nitric Oxide Biol. Chem."},{"issue":"1","key":"10.1016\/j.vph.2016.12.003_bb0190","doi-asserted-by":"crossref","first-page":"H326","DOI":"10.1152\/ajpheart.00744.2006","article-title":"5\u2032-AMP-activated protein kinase activation prevents postischemic leukocyte-endothelial cell adhesive interactions","volume":"292","author":"Gaskin","year":"2007","journal-title":"Ajp Heart Circ. Physiol."},{"issue":"11","key":"10.1016\/j.vph.2016.12.003_bb0195","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1161\/ATVBAHA.110.210500","article-title":"Induction of endothelial nitric oxide synthase, SIRT1, and catalase by statins inhibits endothelial senescence through the Akt pathway","volume":"30","author":"Ota","year":"2010","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"6","key":"10.1016\/j.vph.2016.12.003_bb0200","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1007\/s00125-005-1750-2","article-title":"Enhanced soluble CD40 ligand contributes to endothelial cell dysfunction in vitro and monocyte activation in patients with diabetes mellitus: effect of improved metabolic control","volume":"48","author":"Cipollone","year":"2005","journal-title":"Diabetologia"},{"issue":"4","key":"10.1016\/j.vph.2016.12.003_bb0205","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1160\/TH09-07-0463","article-title":"CD40L induces inflammation and adipogenesis in adipose cells\u2014a potential link between metabolic and cardiovascular disease","volume":"103","author":"Missiou","year":"2010","journal-title":"Thromb. Haemost."},{"issue":"6","key":"10.1016\/j.vph.2016.12.003_bb0210","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.thromres.2014.03.041","article-title":"Platelet activation patterns are different in mouse models of diabetes and chronic inhibition of nitric oxide synthesis","volume":"133","author":"Rozalski","year":"2014","journal-title":"Thromb. Res."},{"issue":"46","key":"10.1016\/j.vph.2016.12.003_bb0215","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1146\/annurev.pharmtox.44.101802.121844","article-title":"The regulation and pharmacology of endothelial nitric oxide synthase","volume":"46","author":"Dudzinski","year":"2006","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"2","key":"10.1016\/j.vph.2016.12.003_bb0220","doi-asserted-by":"crossref","first-page":"130","DOI":"10.3109\/00207454.2014.908876","article-title":"Serotonin depletion can enhance the cerebrovascular responses induced by cortical spreading depression via the nitric oxide pathway","volume":"125","author":"Saengjaroentham","year":"2015","journal-title":"Int. J. Neurosci."},{"issue":"3","key":"10.1016\/j.vph.2016.12.003_bb0225","first-page":"114","article-title":"Vascular hypercontractility and endothelial dysfunction before development of atherosclerosis in moderate dyslipidemia: role for nitric oxide and interleukin-6","volume":"4","author":"Cavieres","year":"2014","journal-title":"Am. J. Cardiovasc. Dis."},{"issue":"28","key":"10.1016\/j.vph.2016.12.003_bb0230","doi-asserted-by":"crossref","first-page":"4580","DOI":"10.2174\/1381612820666140522115801","article-title":"Impact of MCP-1 in atherosclerosis","volume":"20","author":"Lin","year":"2014","journal-title":"Curr. Pharm. Des."},{"issue":"6","key":"10.1016\/j.vph.2016.12.003_bb0235","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/82763","article-title":"IL-6 switches the differentiation of monocytes from dendritic cells to macrophages","volume":"1","author":"Chomarat","year":"2000","journal-title":"Nat. Immunol."},{"issue":"Suppl. 1","key":"10.1016\/j.vph.2016.12.003_bb0240","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1016\/j.amjmed.2008.10.015","article-title":"\u201cSick fat,\u201d metabolic disease, and atherosclerosis","volume":"122","author":"Bays","year":"2009","journal-title":"Am. J. Med."},{"issue":"2","key":"10.1016\/j.vph.2016.12.003_bb0245","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1160\/TH09-05-0297","article-title":"How much is too much? Interleukin-6 and its signalling in atherosclerosis","volume":"102","author":"Schuett","year":"2009","journal-title":"Thromb. Haemost."},{"issue":"7","key":"10.1016\/j.vph.2016.12.003_bb0250","doi-asserted-by":"crossref","first-page":"11324","DOI":"10.3390\/ijms150711324","article-title":"Endothelial dysfunction in chronic inflammatory diseases","volume":"15","author":"Steyers","year":"2013","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.vph.2016.12.003_bb0255","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.cmet.2014.07.023","article-title":"SUMOylation-dependent LRH-1\/PROX1 interaction promotes atherosclerosis by decreasing hepatic reverse cholesterol transport","volume":"20","author":"Stein","year":"2014","journal-title":"Cell Metab."},{"issue":"3","key":"10.1016\/j.vph.2016.12.003_bb0260","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1677\/JOE-09-0271","article-title":"Liver X receptor in cholesterol metabolism","volume":"204","author":"Zhao","year":"2010","journal-title":"J. Endocrinol."},{"issue":"Suppl. 7","key":"10.1016\/j.vph.2016.12.003_bb0265","first-page":"31","article-title":"Biological role of liver X receptors","volume":"59","author":"Baranowski","year":"2009","journal-title":"J. Physiol. Pharmacol."},{"issue":"4","key":"10.1016\/j.vph.2016.12.003_bb0270","doi-asserted-by":"crossref","first-page":"640","DOI":"10.4161\/cc.10.4.14863","article-title":"Protective roles of SIRT1 in atherosclerosis","volume":"10","author":"Stein","year":"2011","journal-title":"Cell Cycle"},{"issue":"1","key":"10.1016\/j.vph.2016.12.003_bb0275","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/jcb.22240","article-title":"SIRT1: a novel target to prevent atherosclerosis","volume":"108","author":"Yu","year":"2009","journal-title":"J. Cell. Biochem."},{"issue":"1","key":"10.1016\/j.vph.2016.12.003_bb0280","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3892\/mmr.2013.1460","article-title":"SIRT1 prevents atherosclerosis via liver-X-receptor and NF-\u03baB signaling in a U937 cell model","volume":"8","author":"Zeng","year":"2013","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.vph.2016.12.003_bb0285","first-page":"736","article-title":"Liver X receptors (LXRs). Part I: structure, function, regulation of activity, and role in lipid metabolism","volume":"61","author":"W\u00f3jcicka","year":"2007","journal-title":"Postepy Hig. Med. Dosw."}],"container-title":["Vascular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189116302749?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189116302749?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,20]],"date-time":"2022-07-20T22:57:26Z","timestamp":1658357846000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1537189116302749"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":57,"alternative-id":["S1537189116302749"],"URL":"https:\/\/doi.org\/10.1016\/j.vph.2016.12.003","relation":{},"ISSN":["1537-1891"],"issn-type":[{"value":"1537-1891","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"G004, a synthetic sulfonylurea compound, exerts anti-atherosclerosis effects by targeting SIRT1 in ApoE\u2212\/\u2212 mice","name":"articletitle","label":"Article Title"},{"value":"Vascular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vph.2016.12.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}